Recent Finacing
Recent Raise
GangaGen develops bacteriophage-based therapeutics targeting antibiotic-resistant bacterial infections (e.g., MRSA, Staphylococcus) for medical, veterinary, and agricultural applications, advancing Klebicin through lead optimization.